Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adacel Booster CMI Assay Development
NCT04543669Phase 4Completed
- Sponsor
- Dalhousie University
- Start
- Jul 2017
- Primary completion
- Sep 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acellular pertussis vaccine in pertussis, Tetanus and diphtheria, sponsored by Dalhousie University. Primary endpoints: CD4 T-cell proliferation, CD8 T-cell proliferation and 2 more. Started Jul 2017; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussisTetanusdiphtheria
Beyond the preview
Go deeper on NCT04543669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04543669.